News New Data From an Influenza Challenge Study Further Support the Prophylactic Potential of INNA-051 to Accelerate Viral Clearance Staff September 11, 2023 Iframe sync Post navigation Previous: SpringWorks Therapeutics Appoints Dr. Tai-An Lin as Chief Scientific OfficerNext: Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance More Stories Healthcare News Pharmaceutical President Trump’s Cannabis Decision Is Coming – And Why MMJ International Holdings Wins Either Way Staff December 13, 2025 Clinical Trial EHR Healthcare News Pharmaceutical Milestone Receives FDA Approval of CARDAMYST™ (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT) Staff December 13, 2025 Clinical Trial News Accelerating Patient Recruitment and Research Excellence: TrialWire® Supports Endpoints Clinical Trials Day NYC 2025 Staff December 13, 2025
